Stock Events

Stock Events

Quantum BioPharma 

€4.53
144
+€0.08+1.89% Today

Statistics

Day High
4.53
Day Low
4.53
52W High
30.8
52W Low
1.82
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

8MayExpected
Next
-0.42
-0.09
0.25
0.58
Expected EPS
-0.41848447217117396
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0K91.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap993.36M
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a direct competitor in the cannabis market.
Tilray Brands
TLRY
Mkt Cap736.76M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, competing in the same market as FSD Pharma.
Canopy Growth
CGC
Mkt Cap507.46M
Canopy Growth Corporation operates in the cannabis and hemp business, directly competing with FSD Pharma in the cannabis industry.
Aurora Cannabis
ACB
Mkt Cap205.76M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, competing in the same industry as FSD Pharma.
Green Thumb Industries
GTBIF
Mkt Cap1.81B
Green Thumb Industries is involved in the cultivation, sale, and distribution of cannabis products, making it a competitor in the cannabis industry alongside FSD Pharma.

About

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada.
Show more...
CEO
ISIN
CA74764Y2050

Listings

MU
DE
0K91.MU
STU
DE
0K91.STU
CN
CA
QNTM.CN
F
DE
0K91.F

0 Comments

Share your thoughts

FAQ

What is Quantum BioPharma stock price today?▼
The current price of 0K91.MU is €4.53 EUR — it has increased by +1.89% in the past 24 hours. Watch Quantum BioPharma stock price performance more closely on the chart.
What is Quantum BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quantum BioPharma stocks are traded under the ticker 0K91.MU.
Is Quantum BioPharma stock price growing?▼
0K91.MU stock has fallen by -0.57% compared to the previous week, the month change is a +18.02% rise, over the last year Quantum BioPharma has showed a -42.99% decrease.
When is the next Quantum BioPharma earnings date?▼
Quantum BioPharma is going to release the next earnings report on May 08, 2026.
In which sector is Quantum BioPharma located?▼
Quantum BioPharma operates in the Other sector.
When did Quantum BioPharma complete a stock split?▼
The last stock split for Quantum BioPharma was on October 27, 2025 with a ratio of 1:1.